Αποτελέσματα Αναζήτησης
ONCEPT ® Canine Melanoma Vaccine, DNA is a safe, effective adjunct therapy that can significantly prolong survival times in dogs with stage II or stage III canine oral melanoma (COM) for which local disease control has been achieved by traditional means. 2
15 Σεπ 2022 · FAQ #5: What is the ONCEPT® melanoma vaccine for dogs? Prior to 2007, surgery, chemotherapy, and radiation were the only options for treating canine oral malignant melanoma. With the development of a melanoma vaccine called ONCEPT, the veterinary community gained an exciting treatment option.
The average cost per injection is $$$ to $$$$ (see Cost Key), making the overall cost comparable with that for chemotherapy. Dogs receive an initial induction series of 4 injections 2 weeks apart and then a booster q6mo.
Systemic immunotherapy for adjuvant treatment of canine melanoma may be more promising than chemotherapy. A xenogeneic DNA vaccine, Oncept (Boehringer Ingelheim, petcancervaccine.com ), has made headway as the first conditionally approved immunotherapy for the treatment of canine OMM.
The Oncept melanoma vaccine is xenogeneic DNA vaccine targeting tyrosinase. It is USDA approved for treatment of stage II to III canine oral melanoma and is also used off-label for melanomas arising in other locations and in other species.
Recent advances in the treatment for the metastatic potential of melanoma have occurred with the melanoma vaccine, Oncept. The goal of the Oncept vaccine is to stimulate the immune system to target melanoma cells in the body.
28 Οκτ 2022 · The Oncept melanoma vaccine is xenogeneic DNA vaccine targeting tyrosinase. It is USDA approved for treatment of stage II to III canine oral melanoma and is also used off-label for melanomas arising in other locations and in other species.
